SlidesetHIVStrategies to improve metabolic risk factors in HIV infected patients - Andrew Carr, MD, MBBSView Slideset
SlidesetHIVLong term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MDView Slideset
SlidesetHIVUpdate on the development of the HIV Fourth 90 consensus statement - Jeffrey V. Lazarus, PhD, MIHView Slideset
SlidesetHIVLong term prevention of reduced renal function in PLWH - Jeremy Levy, MA, PhD, DSc(Hon), FHEA, FRCPView Slideset
SlidesetHIVMaximizing PrEP use and retention at the national level - Julia Del Amo, MD, PhDView Slideset
SlidesetHIVSuccessful introduction of PrEP in challenging community settings - Justyna Kowalska, MD, PhDView Slideset
SlidesetHIVEthnic, gender and cultural considerations in PROMs and their significance - Giulio Maria CorbelliView Slideset
SlidesetHIVPrEP and new delivery systems: What does the future hold? - Raphael Landovitz, MD, MScView Slideset
SlidesetHIVImproved adherence with non-PO medications: What are the data? - Susan Swindells, MBBSView Slideset
SlidesetHIVIntroduction of PrEP in challenging community settings (Czech Republic) - Zofia Bartovska, PhDView Slideset
SlidesetHIVExperiences Engaging in a Group-Based Physiotherapist-Led Exercise Program for Adults Living with HIV and Complex Multimorbidity: A Qualitative Study - Alex RuthView Slideset
SlidesetHIVHIV/AIDS treatment in Elderly Women: Experiences, Unique Ch-allenges, and lessons learned - Sendaula EmanuelView Slideset
SlidesetHIVTele-counseling Helps Maintain Employee Productivity and Patient Reach in the Context of the COVID-19 Pandemic for HIV Patients from Baylor Black Sea Foundation (BBSF), Romania - Elena RizeaView Slideset
SlidesetHIVMeet Marvin, the Chatbot: Using Artificial Intelligence to Engage HIV Patients in their Antiretroviral Therapy - Yuanchao MAView Slideset
